Table of Contents

company-logo

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

Crinetics Pharmaceuticals Dividend Announcement

• Crinetics Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Crinetics Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Crinetics Pharmaceuticals Dividend History

Crinetics Pharmaceuticals Dividend Yield

Crinetics Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Crinetics Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Crinetics Pharmaceuticals Financial Ratios

P/E ratio-18.34
PEG ratio0.49
P/B ratio5.71
ROE-62.63%
Payout ratio0.00%
Current ratio16.09
Quick ratio16.09
Cash Ratio5.56

Crinetics Pharmaceuticals Dividend FAQ

Does Crinetics Pharmaceuticals stock pay dividends?
Crinetics Pharmaceuticals does not currently pay dividends to its shareholders.
Has Crinetics Pharmaceuticals ever paid a dividend?
No, Crinetics Pharmaceuticals has no a history of paying dividends to its shareholders. Crinetics Pharmaceuticals is not known for its dividend payments.
Why doesn't Crinetics Pharmaceuticals pay dividends?
There are several potential reasons why Crinetics Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Crinetics Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Crinetics Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Crinetics Pharmaceuticals a dividend aristocrat?
Crinetics Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Crinetics Pharmaceuticals a dividend king?
Crinetics Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Crinetics Pharmaceuticals a dividend stock?
No, Crinetics Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Crinetics Pharmaceuticals stocks?
To buy Crinetics Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Crinetics Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.